Wolverine Trading, LLC Esperion Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $37,720 - $66,420	20,500 New	20,500 $45,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $76,350 - $127,500	15,000 New	15,000 $93,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $55,314 - $137,080	-11,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.34 - $21.37 $130,410 - $245,755	11,500 New	11,500 $143,000
Q2 2021 Aug 06, 2021	SELL	$19.4 - $28.71 $275,480 - $407,682	-14,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$25.12 - $36.89 $356,704 - $523,838	14,200 New	14,200 $390,000
Q2 2020 Aug 13, 2020	SELL	$30.04 - $51.31 $294,392 - $502,838	-9,800 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$27.44 - $73.84 $71,344 - $191,984	2,600 Added 36.11%	9,800 $333,000
Q4 2019 Feb 12, 2020	SELL	$35.4 - $59.82 $162,840 - $275,172	-4,600 Reduced 38.98%	7,200 $431,000
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $158,562 - $218,638	-4,600 Reduced 28.05%	11,800 $446,000
Q2 2019 Aug 20, 2019	SELL	$40.1 - $52.33 $184,460 - $240,718	-4,600 Reduced 21.9%	16,400 $763,000
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $232,638 - $310,706	5,800 Added 38.16%	21,000 $843,000
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $562,248 - $898,472	15,200 New	15,200 $671,000
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $2.52 Million - $3.18 Million	-61,900 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $3.44 Million - $4.22 Million	52,200 Added 538.14%	61,900 $4.48 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $8,694 - $13,486	200 Added 2.11%	9,700 $639,000
Q3 2017 Nov 15, 2017	BUY	$43.8 - $52.77 $416,100 - $501,315	9,500	9,500 $476,000

Others Institutions Holding ESPR

# of Institutions

207

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account